[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Phraxis, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":20,"conditions":21,"keywords":23,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100604233",false,"NCT07146854","EndoForce Post Approval Study","Inclusion Criteria:\n\n* Patient is ≥18 years of age.\n* Patient requires the creation of a vascular access graft for hemodialysis, secondary to a diagnosis of ESRD.\n* Patient is able to have the vascular access ePTFE graft placed in an upper arm.\n* Patient or his\u002Fher legal guardian understands the study and is willing and able to comply with the dialysis schedule and follow-up requirements.\n* Patient or his\u002Fher legal guardian provides written informed consent.\n\nExclusion Criteria:\n\n* All contraindications for the EndoForce Connector System according to the IFU.\n* Patient is pregnant.\n* Patient is enrolled in another dialysis or vascular investigational study, without prior approval from the Sponsor.","ALL","18 Years",{"count":17,"type":18},150,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to collect long-term safety and performance data for the use of the EndoForce System for connecting a hemodialysis graft to a vein in patients with End Stage Renal Disease. This is not an experimental procedure or an experimental therapy. This means that the study device has been approved by the FDA.",[22],"End Stage Renal Disease (ESRD)",[24,25],"Hemodialysis","Arteriovenous graft","RECRUITING","2026-01-16",{"date":29,"type":30},"2026-01-21","ACTUAL",{"date":32,"type":30},"2026-01-13",{"date":34,"type":18},"2029-12",{"name":36,"class":37},"Phraxis, Inc.","INDUSTRY",2,""]